Pigs have already been vaccinated and will be challenged with a virulent strain of the ASF virus to assess the vaccine’s efficacy.
The approval allows Genus to commercialise its PRRS-resistant pigs, dubbed PRP, for the U.S. market, though sales are not expected until 2026 at the earliest.
The Philippine Department of Agriculture recently launched a new ASF vaccine research centre at Central Luzon State University to strengthen the nation’s biosecurity infrastructure.
ASF has devastated pig populations in parts of Asia, Europe, and Africa in recent years and controlling its spread is a top priority for the global pork industry.
This innovation has the potential to significantly reduce the economic losses caused by ASFV in the global swine industry.